O‐GlcNAcylation of CSNK2A1 by OGT is Involved in the Progression of Colorectal Cancer
Molecular Biotechnology · 2025-01 · 67 (1) · 272-283
DOI: 10.1007/s12033-024-01049-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biotechnology, online erschienen am 30.01.2024. Verfasst von Zhengyao Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Anorectal Surgery, The First People's Hospital of Chun'an County (Chun'an Branch of Zhejiang Provincial People's Hospital), 1869 Huanhu North Road, Q…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, N-Acetylglucosaminyltransferases, Cell Proliferation, Casein Kinase II. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Colorectal cancer (CRC) metastasis is challenging for improved clinical outcomes. The casein kinase 2 alpha 1 (CSNK2A1) is an oncogene involved in several cancers. This study aimed to investigate the influence of CSNK2A1 on CRC progression and the related molecular mechanism. The CSNK2A1 levels were predicted using bioinformatic analysis and were measured using quantitative real-time polymerase chain reaction (qRT-PCR). Cell phenotypes were analyzed using cell-counting kit-8, colony formation, transwell assay, and western blot. Tumor growth was evaluated in a tumor-bearing mouse model in vivo. Similarly, O-GlcNAc modification of CSNK2A1 was assessed by immunoprecipitation, western blot, and immunofluorescence. Results indicated that CSNK2A1 was upregulated in CRC and was related to poor prognosis. Interference with CSNK2A1 suppressed CRC cell proliferation, migration, invasion, and epithelial-mesenchymal transition, inhibiting tumor growth. Moreover, OGT promoted the glycosylation modification of CSNK2A1, enhanced its protein stability, and reversed tumor progression when CSNK2A1 was knocked down. The CSNK2A1 might also affect CRC progression via the PI3K/AKT pathway. In conclusion, the OGT-O-GlcNAcylation-CSNK2A1 axis accelerated the malignant advancement of CRC, suggesting potential CRC therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Anorectal Surgery, The First People's Hospital of Chun'an County (Chun'an Branch of Zhejiang Provincial People's Hospital), 1869 Huanhu North Road, Qiandaohu, Chun'an, 311700, Zhejiang, China.
- Endoscopy Room, The First People's Hospital of Chun'an County (Chun'an Branch of Zhejiang Provincial People's Hospital), 1869 Huanhu North Road, Qiandaohu, Chun'an, 311700, Zhejiang, China.
- Surgery Department, Chun'an County Hospital of Traditional Chinese Medicine (Chun'an Branch of Hangzhou Hospital of Traditional Chinese Medicine), No. 1, Xin'an West Road, Qiandaohu, Chun'an, 311700, Zhejiang, China. hu…
Zitieren
APA
Yu, Z., He, H., Jiang, B., & Hu, J. (2025). O‐GlcNAcylation of CSNK2A1 by OGT is Involved in the Progression of Colorectal Cancer. Molecular Biotechnology, 67(1), 272-283. https://doi.org/10.1007/s12033-024-01049-1
Vancouver
Yu Z, He H, Jiang B, Hu J. O‐GlcNAcylation of CSNK2A1 by OGT is Involved in the Progression of Colorectal Cancer. Molecular Biotechnology. 2025;67(1):272-283. doi:10.1007/s12033-024-01049-1
BibTeX
@article{Yu2025,
author = {Yu, Zhengyao and He, Huijuan and Jiang, Baoying and Hu, Jing},
title = {O‐GlcNAcylation of CSNK2A1 by OGT is Involved in the Progression of Colorectal Cancer},
journal = {Molecular Biotechnology},
year = {2025},
volume = {67},
number = {1},
pages = {272--283},
doi = {10.1007/s12033-024-01049-1}
}
EUVIMED